Citation Impact
Citing Papers
Characterization of MicroRNA Expression Levels and Their Biological Correlates in Human Cancer Cell Lines
2007 StandoutNobel
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Gene expression profiling of malignant mesothelioma.
2003
Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response.
1999
Structure, Orientation, and Conformational Changes in Transmembrane Domains of Multidrug Transporters
2004
The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane
1999
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum
2000
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
1999
Soft Tissue Leiomyosarcomas and Malignant Gastrointestinal Stromal Tumors: Differences in Clinical Outcome and Expression of Multidrug Resistance Proteins
2000
Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung.
1998
An inventory of the human ABC proteins
1999
Sensitivity of Non-Small-Cell Lung Cancer Cell Lines Established from Patients Treated with Prolonged Infusions of Paclitaxel
2003
A gene expression database for the molecular pharmacology of cancer
2000 Nobel
Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer
2000
P‐glycoprotein, lung resistance‐related protein and multidrug resistance associated protein in de novo acute non‐lymphocytic leukaemias: biological and clinical implications
1999
Systematic variation in gene expression patterns in human cancer cell lines
2000 Standout
Vaults and Telomerase Share a Common Subunit, TEP1
1999
Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance
1999
Molecular mechanisms of drug resistance
2005
Differential and Simultaneous Adenosine Di- and Triphosphate Binding by MutS
2003 StandoutNobel
Vaults: a ribonucleoprotein particle involved in drug resistance?
2003
Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor
2001 Standout
Molecular characterisation of soft tissue tumours: a gene expression study
2002 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Head and neck cancer
2008 Standout
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Allosteric Interactions between the Two Non-equivalent Nucleotide Binding Domains of Multidrug Resistance Protein MRP1
2000
Resistance mechanisms to cancer chemotherapy
2008
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
2005 StandoutNature
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
Principles of bioactive lipid signalling: lessons from sphingolipids
2008 Standout
Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy
2005 Standout
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2006 Standout
Different strategies to overcome multidrug resistance in cancer
2013
Expression of Drug Resistance‐related Genes in Head and Neck Squamous Cell Carcinoma and Normal Mucosa
2000
Fluorescent and colorimetric probes for detection of thiols
2010 Standout
Regulation of Ferroptotic Cancer Cell Death by GPX4
2014 Standout
Clinical resistance to topoisomerase-targeted drugs
1998
Cellular processing of platinum anticancer drugs
2005 Standout
Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer
2003
Air pollution and health
2002 Standout
Protein–Protein Docking with Backbone Flexibility
2007 StandoutNobel
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Oxidative stress and regulation of glutathione in lung inflammation
2000
Apoptosis
2002 Standout
Poly(ADP-ribose): novel functions for an old molecule
2006 Standout
Molecular signals in anti-apoptotic survival pathways
2001
Differential Specificities and Simultaneous Occupancy of Human MutSα Nucleotide Binding Sites
2004 StandoutNobel
The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
2003 Standout
Recent progress in tumor pH targeting nanotechnology
2008
Copper‐transporting P‐type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: Comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP
2002
Predicting drug sensitivity and resistance
2004
A protein expression database for the molecular pharmacology of cancer
1997
Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients
2005
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
ABC transporters in lipid transport
2000
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin
2003
Assay and screening methods for bioactive substances based on cellular signaling pathways
2002
MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver
1999
The NCI60 human tumour cell line anticancer drug screen
2006 Standout
Clinical Perspectives on Platinum Resistance
2000
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Structure of the vault, a ubiquitous celular component
1999
Advances in Malignant Mesothelioma
2005 Standout
Heat shock proteins – modulators of apoptosis in tumour cells
2000
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Model-Based Clustering, Discriminant Analysis, and Density Estimation
2002 Standout
Tetrahymena proteins p80 and p95 are not core telomerase components
2001 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
2003 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
TELOMERES AND THEIR CONTROL
2000 StandoutNobel
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
Mutational Disruption of Plasma Membrane Trafficking of Saccharomyces cerevisiae Yor1p, a Homologue of Mammalian Multidrug Resistance Protein
1999
Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
1997
Biology of Gastrointestinal Stromal Tumors
2004 Standout
Reversal of anticancer multidrug resistance by the ardeemins
1998
Epitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP)
1998
Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow
2005
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Lipopolysaccharide Endotoxins
2002 Standout
Identification of Chemoresistance-Related Cell-Surface Glycoproteins in Leukemia Cells and Functional Validation of Candidate Glycoproteins
2014
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Mining the National Cancer Institute's Tumor-Screening Database: Identification of Compounds with Similar Cellular Activities
2002
The 193-Kd Vault Protein, Vparp, Is a Novel Poly(Adp-Ribose) Polymerase
1999
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
2011 StandoutScience
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Chemical Glycoproteomics
2016 StandoutNobel
Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies.
2000
Works of Marcel J. Flens being referenced
Relationship of LRP-human major vault protein toin vitro and clinical resistance to anticancer drugs
1996
Immunohistochemical Analysis of Drug Resistanceassociated Proteins in Ovarian Carcinomas
2000
Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines
1996
Expression of the vascular endothelial cell protein C receptor in epithelial tumour cells
2002
The drug resistance-related protein LRP is the human major vault protein
1995
MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lung
1996
Membrane Topology and Glycosylation of the Human Multidrug Resistance-associated Protein
1996
Overlapping phenotypes of multidrug resistance among panels of human cancer‐cell lines
1996